Incredible” results from the PATINA trial suggested a new standard of care for HER2, ER-positive metastatic breast cancer.

Texas Attorney General Ken Paxton filed a notice of appeal on Wednesday to continue his lawsuit against Pfizer Inc., for its ...

Nurix Therapeutics (NRIX) leads in targeted protein modulation with its DELigase platform, developing BTK degraders like ...

When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...

Using LEDs has the potential to bring down the cost of biomanufacturing, allowing such processes to make materials that ...

The move will place students in good stead to take up skilled roles in biopharma manufacturing. Read more at straitstimes.com ...

NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2025 of $0.22 per Class A ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

Beyond the influence of new therapies on drug pricing trends, Cowen’s report also accounted for the effects of legislation ...

Austin Police Department detectives are investigating the second homicide of 2025 after a body was found at an apartment ...

Austin Pets Alive! is kicking off its year with its monthly Second Chance Saturday event on January 11th. Read more: ...